You are Trying to View a Free ArticleDaily News You Can't Find Anywhere Else
Bayer and Orion Submit Application for EU Approval, an Industrial Info Market Brief
Industry Segment: Pharmaceutical & Biotech | Word Count: 80 Words
Attachment: Bayer and Orion European Spending
Bayer and Orion Corporation are seeking permission from the European Union (EU) to market Darolutamide for the treatment of patients with non-metastatic castration-resistant prostate cancer.
Subscribe Now! All Fields Required...
- Pharma-Bio Industry Grassroot Plant Investment at $68 Billion, an Industria...
- Seattle Evolves As Biotech Hub, an Industrial Info Market Brief
- Cosmetics Sector Booms in Europe, an Industrial Info Market Brief
- API Production in India to Improve by 2020, an Industrial Info Market Brief
- Europe Launches High-Tech System to Detect Fake Medicines
- Current Economic Indicators
- Free Daily Industrial Articles
- Monthly Industrial Newsletter
- IIR's Disaster Impact Tracker